CDK4 and neuroblastoma: Among the 13 oncogenic target genes that we identified, only 2 genes, CDK4 and EZH2, have been clearly demonstrated to have a strong function in modulating neuroblastoma cell differentiation, with knocking down expression of these 2 genes inducing neuroblastoma cell differentiation [12,13], which is consistent with the previous findings.